https://stock.noler.com/us/stock/unigene-laboratories-inc https://stock.noler.com/us/stock/unigene-laboratories-inc/accounts-payable https://stock.noler.com/us/stock/unigene-laboratories-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/unigene-laboratories-inc/accounts-receivable https://stock.noler.com/us/stock/unigene-laboratories-inc/accrued-bonuses-current https://stock.noler.com/us/stock/unigene-laboratories-inc/accrued-liabilities-current https://stock.noler.com/us/stock/unigene-laboratories-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/unigene-laboratories-inc/accumulated-depreciation https://stock.noler.com/us/stock/unigene-laboratories-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/unigene-laboratories-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/unigene-laboratories-inc/additional-paid-in-capital https://stock.noler.com/us/stock/unigene-laboratories-inc/adjustment-for-amortization https://stock.noler.com/us/stock/unigene-laboratories-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/amended-reports-10-k https://stock.noler.com/us/stock/unigene-laboratories-inc/amended-reports-10-q https://stock.noler.com/us/stock/unigene-laboratories-inc/amortization https://stock.noler.com/us/stock/unigene-laboratories-inc/amortization-of-deferred-charges https://stock.noler.com/us/stock/unigene-laboratories-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/unigene-laboratories-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/asset-impairment-charges https://stock.noler.com/us/stock/unigene-laboratories-inc/basic-shares https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-expenditures https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/unigene-laboratories-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/unigene-laboratories-inc/cash-and-equivalents https://stock.noler.com/us/stock/unigene-laboratories-inc/cash-flow-breakdown https://stock.noler.com/us/stock/unigene-laboratories-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/unigene-laboratories-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/unigene-laboratories-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/unigene-laboratories-inc/clinical-trials https://stock.noler.com/us/stock/unigene-laboratories-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/unigene-laboratories-inc/common-stock-value https://stock.noler.com/us/stock/unigene-laboratories-inc/compensating-balance-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/contractual-obligation https://stock.noler.com/us/stock/unigene-laboratories-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/unigene-laboratories-inc/convertible-notes-payable https://stock.noler.com/us/stock/unigene-laboratories-inc/cost-of-goods-sold https://stock.noler.com/us/stock/unigene-laboratories-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/unigene-laboratories-inc/current-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/current-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/damages-sought-value https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-carrying-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-face-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-issuance-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-issued https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-periodic-payment https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-repaid https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-unamortized-discount https://stock.noler.com/us/stock/unigene-laboratories-inc/debt-unamortized-premium https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-revenue https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-derivative-instruments https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-equity-method-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-tax-deferred-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-compensated-absences https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-compensation https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/unigene-laboratories-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/depreciation https://stock.noler.com/us/stock/unigene-laboratories-inc/depreciation-and-amortization https://stock.noler.com/us/stock/unigene-laboratories-inc/derivative-basis-spread-on-variable-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/derivative-liability-notional-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/diluted-shares https://stock.noler.com/us/stock/unigene-laboratories-inc/due-from-joint-ventures-current https://stock.noler.com/us/stock/unigene-laboratories-inc/due-to-affiliate-current https://stock.noler.com/us/stock/unigene-laboratories-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/unigene-laboratories-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/unigene-laboratories-inc/embedded-derivative-fair-value-of-embedded-derivative-net https://stock.noler.com/us/stock/unigene-laboratories-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/unigene-laboratories-inc/embedded-derivative-gain-on-embedded-derivative https://stock.noler.com/us/stock/unigene-laboratories-inc/embedded-derivative-loss-on-embedded-derivative https://stock.noler.com/us/stock/unigene-laboratories-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/unigene-laboratories-inc/eps https://stock.noler.com/us/stock/unigene-laboratories-inc/eps-basic https://stock.noler.com/us/stock/unigene-laboratories-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/unigene-laboratories-inc/equity-method-investment-realized-gain-loss-on-disposal https://stock.noler.com/us/stock/unigene-laboratories-inc/equity-method-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/facility-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-inputs-comparability-adjustments https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-inputs-probability-of-default https://stock.noler.com/us/stock/unigene-laboratories-inc/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/unigene-laboratories-inc/fees-and-commissions-other https://stock.noler.com/us/stock/unigene-laboratories-inc/financing-cash-flow https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/unigene-laboratories-inc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/form-d-other https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-loss-on-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/gain-on-sale-of-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/gains-losses-on-sales-of-other-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/unigene-laboratories-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/income-tax https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-customer-advances-and-deposits https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-deferred-compensation https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/unigene-laboratories-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/unigene-laboratories-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/unigene-laboratories-inc/insider-transactions-other https://stock.noler.com/us/stock/unigene-laboratories-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/unigene-laboratories-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-and-other-income https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-expense-on-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-paid https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-payable-current https://stock.noler.com/us/stock/unigene-laboratories-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory-work-in-process https://stock.noler.com/us/stock/unigene-laboratories-inc/inventory-write-down https://stock.noler.com/us/stock/unigene-laboratories-inc/investing-cash-flow https://stock.noler.com/us/stock/unigene-laboratories-inc/investments-in-affiliates-subsidiaries-associates-and-joint-ventures https://stock.noler.com/us/stock/unigene-laboratories-inc/investments-in-affiliates-subsidiaries-associates-and-joint-ventures-fair-value-disclosure https://stock.noler.com/us/stock/unigene-laboratories-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/unigene-laboratories-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/unigene-laboratories-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/unigene-laboratories-inc/lease-and-rental-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/licenses-revenue https://stock.noler.com/us/stock/unigene-laboratories-inc/line-of-credit-facility-increase-additional-borrowings https://stock.noler.com/us/stock/unigene-laboratories-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/unigene-laboratories-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/unigene-laboratories-inc/minority-interest-in-net-income-loss-joint-venture-partners https://stock.noler.com/us/stock/unigene-laboratories-inc/net-change-in-cash https://stock.noler.com/us/stock/unigene-laboratories-inc/net-income https://stock.noler.com/us/stock/unigene-laboratories-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/unigene-laboratories-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/unigene-laboratories-inc/noncash-or-part-noncash-acquisition-debt-assumed https://stock.noler.com/us/stock/unigene-laboratories-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/unigene-laboratories-inc/noncash-or-part-noncash-acquisition-investments-acquired https://stock.noler.com/us/stock/unigene-laboratories-inc/notes-payable https://stock.noler.com/us/stock/unigene-laboratories-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/unigene-laboratories-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-cash-flow https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-expenses https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-income https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/unigene-laboratories-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/unigene-laboratories-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/unigene-laboratories-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/unigene-laboratories-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/unigene-laboratories-inc/other-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/other-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/unigene-laboratories-inc/other-current-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/other-deferred-cost-amortization-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/other-long-term-notes-payable https://stock.noler.com/us/stock/unigene-laboratories-inc/other-noncurrent-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/other-notes-payable-current https://stock.noler.com/us/stock/unigene-laboratories-inc/other-receivables https://stock.noler.com/us/stock/unigene-laboratories-inc/other-sales-revenue-net https://stock.noler.com/us/stock/unigene-laboratories-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/unigene-laboratories-inc/paid-in-capital-other https://stock.noler.com/us/stock/unigene-laboratories-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-for-capital-improvements https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-of-financing-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/payments-to-acquire-interest-in-joint-venture https://stock.noler.com/us/stock/unigene-laboratories-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/unigene-laboratories-inc/pretax-income https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-license-fees-received https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-sale-of-other-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/unigene-laboratories-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/unigene-laboratories-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/property-plant-equipment https://stock.noler.com/us/stock/unigene-laboratories-inc/public-float https://stock.noler.com/us/stock/unigene-laboratories-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/unigene-laboratories-inc/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/unigene-laboratories-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/unigene-laboratories-inc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/unigene-laboratories-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/research-and-development https://stock.noler.com/us/stock/unigene-laboratories-inc/retained-earnings https://stock.noler.com/us/stock/unigene-laboratories-inc/revenue https://stock.noler.com/us/stock/unigene-laboratories-inc/revenue-from-grants https://stock.noler.com/us/stock/unigene-laboratories-inc/royalty-revenue https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-annual-rental-payments https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-cumulative-gain-recognized https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-current-period-gain-recognized https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-deferred-gain-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-deferred-gain-net https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-gross-proceeds https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-net-book-value https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-net-proceeds https://stock.noler.com/us/stock/unigene-laboratories-inc/sale-leaseback-transaction-other-payments-required https://stock.noler.com/us/stock/unigene-laboratories-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-10-k https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-10-q https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-8-k https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-ct-order https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-def-14a https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-defa14a https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-defr14a https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-regdex https://stock.noler.com/us/stock/unigene-laboratories-inc/sec-filings-revoked https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/unigene-laboratories-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/unigene-laboratories-inc/severance-costs https://stock.noler.com/us/stock/unigene-laboratories-inc/sga-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/unigene-laboratories-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/unigene-laboratories-inc/share-based-goods-and-nonemployee-services-transaction-stockholders-equity https://stock.noler.com/us/stock/unigene-laboratories-inc/share-price https://stock.noler.com/us/stock/unigene-laboratories-inc/shareholders-equity https://stock.noler.com/us/stock/unigene-laboratories-inc/shares-authorized https://stock.noler.com/us/stock/unigene-laboratories-inc/shares-issued https://stock.noler.com/us/stock/unigene-laboratories-inc/shares-issued-2 https://stock.noler.com/us/stock/unigene-laboratories-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/unigene-laboratories-inc/short-term-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-based-compensation https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/unigene-laboratories-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/unigene-laboratories-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/unigene-laboratories-inc/total-assets https://stock.noler.com/us/stock/unigene-laboratories-inc/total-liabilities https://stock.noler.com/us/stock/unigene-laboratories-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/unigene-laboratories-inc/total-long-term-debt https://stock.noler.com/us/stock/unigene-laboratories-inc/treasury-stock-shares https://stock.noler.com/us/stock/unigene-laboratories-inc/treasury-stock-value https://stock.noler.com/us/stock/unigene-laboratories-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/unigene-laboratories-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/unigene-laboratories-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/unigene-laboratories-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/unigene-laboratories-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/unigene-laboratories-inc/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/unigene-laboratories-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/unigene-laboratories-inc/weighted-average-number-of-share-outstanding-basic-and-diluted